Swisher Daniel N Jr
Director | President And COO | President And CEO
4 companies
Insider Signal Score
49
AverageTrades Analyzed
35
12M Win Rate
30.0%
Avg 3M Return
-4.1%
Avg 12M Return
-32.8%
Swisher Daniel N Jr is a President And CEO at Viracta Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $14.8M based on current market prices.
Holdings by Company
VIRXFeb 29, 2016
Current Shares266.5K
Est. Value$199.9K
Net Activity+37.3K
Bought: 50.0KSold: 12.7K
CERSJun 3, 2025
Current Shares207.0K
Value$480.3K
Net Activity-41,877
Bought: 8.5KSold: 50.4K
JAZZMar 5, 2023
Current Shares55.0K
Value$14.12M
Net Activity0
Bought: 0Sold: 0
CORTOct 10, 2025
Current Shares0
Value-
Net Activity-113,035
Bought: 0Sold: 113.0K
Transaction History
Showing 4 filings (page 5)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2020 | CERS Cerus Corp | Director | Buy | 1,000 | $4.15 | $4,150.00 | +2.2% | |
| Aug 25, 2015 | VIRX Viracta Therapeutics, Inc. | President And CEO | Buy | 25,000 | $1.01 | $25,250.00 | +6.9% | |
| Jul 24, 2015 | VIRX Viracta Therapeutics, Inc. | President And CEO | Buy | 25,000 | $1.02 | $25,457.50 | +16.7% | |
| Jul 24, 2015 | VIRX Viracta Therapeutics, Inc. | President And CEO | Sell | 12,715 | $3.46 | $43,974.83 | -4.2% |
← PrevPage 5